Naslov
Current management of psoriasis in Croatia

Autori
Lipozenčić, Jasna ; Pašić, Aida ; Marasović, Dujomir ; Barišić-Druško, Vladimira

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Journal of the European Academy of Dermatology and Venereology / Ortonne, Jean-Paul - Pariz : Wiley-Blackwell, 2004

Skup
Psoriasis 2004 European Congress on Psoriasis

Mjesto i datum
Pariz, Francuska, 21.10.2004. - 24.10.2004

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Psoriasis; managment; topical therapy

Sažetak
Background: New psoriasis therapies offer great hope for the people who suffer from psoriasis and other chronic inflammatory skin diseases. Psoriasis and psoriatic arthritis are the diseases that can be treated with biological therapy which targets either the interaction between an antigen-presenting cell and the T-cell, or cytokines such as tumor necrosis factor alpha (TNF-α ) that are presumed to be involved in the pathogenesis of psoriasis vulgaris and psoriatic arthritis. Objective: Current biologic therapies now seem to hold promise of potentially excellent effect: etanercept ; efalizumab ; infliximab ; macrolides (tacrolimus, pimecrolimus, sirolimus). Methods: Existing therapies: phototherapy (PUVA or UVB) for 4 weeks and for 6 weeks therapy: retinoids (acitretin), cyclosporin, methotrexate (MTX), and in very rare circumstances systemic steroids. Rotational therapy is necessary. Results: Topical therapy will continue to be used in combination with systemic psoriasis management for residual psoriatic plaques. We highlight the current psoriasis management, and their use in everyday practice in Croatia. Conclusion: The new agents may well transform the way that moderate to severe psoriasis is treated.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA